Medicare AdvantageCoverageMedium impact
MA11.056i, Percutaneous Transluminal Angioplasty (PTA) Concurrent with or without Stenting and Extracranial- Intracranial (EC-IC) Arterial Bypass Surgery
Independence Blue Cross·Neurosurgery, Vascular Surgery, Cardiology +1 more·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Policy MA11.056i has been reissued effective 04/01/2026, addressing coverage and billing guidance for Percutaneous Transluminal Angioplasty (PTA) with or without stenting and Extracranial-Intracranial (EC-IC) arterial bypass surgery procedures. The billing team must review the full policy text to identify specific coverage changes, prior authorization requirements, or billing code updates that may affect claim submissions for these neurovascular procedures.
Action Required
By March 15, 2026: Billing team must obtain and review the complete MA11.056i policy text from https://medpolicy.ibx.com/ibc/ma/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=04&FilterField2=MPSiteActivityLogYear&FilterValue2=2026#medicare-advantage-ma11-056i-percutaneous-transluminal-angio. Identify all affected CPT/HCPCS codes, prior authorization requirements, and coverage limitations. Update billing system rules, prior authorization workflows, and provider documentation templates accordingly. Communicate changes to providers performing neurovascular procedures. Beginning April 1, 2026, apply updated billing rules to all PTA and EC-IC bypass claims. Failure to comply may result in claim denials or payment delays.